<DOC>
	<DOC>NCT03010657</DOC>
	<brief_summary>This study evaluates a diet modification in adults undergoing chemotherapy for non-small cell lung cancer. Half of participants will modify their diet, while the other half will continue to eat their habitual diet.</brief_summary>
	<brief_title>Evaluation of a Food Intake Modification for Lung Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Patients with a newly confirmed diagnosis of nonsmall cell lung cancer scheduled for first line chemotherapy Patients with a computed tomography (CT) image, which includes scans of the 3rd lumbar region, taken within 45 days before initiation of chemotherapy Confirmed dietary intake of a specific food group at or below Canada's Food Guide agespecific recommended number of servings per day Ability to maintain oral intake Eastern Cooperative Oncology Group (ECOG) Performance Status ≤2 / Karnofsky Performance Status between 60100 Ability to give written, informed consent Comorbidities that would be expected to interfere with the primary outcome measure Patients on long term drugs or supplements that modify muscle metabolism Life expectancy &lt;3 months Individuals with specific food intolerances or allergies An inability to comply with study instructions Patients without a computed tomography (CT) image, which includes scans of the 3rd lumbar region, taken after 2 cycles of chemotherapy Patients engaged in a total of ≥50 minutes of moderatetovigorous cardiovascular exercise per week and/or structured resistance exercise occurring ≥2 times per week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>